A single dose reversed autism-like symptoms in adult mice within hours - ScienceDaily

What the report says

ScienceDaily reported on a UCLA Health mouse study, published in Nature Communications, that examined how inflammation during pregnancy can affect offspring long after birth. In the experiment, pregnant mice were exposed to a mild inflammatory trigger that did not make the mothers seriously ill. Their adult offspring later showed persistent brain and body inflammation, mild brain overgrowth, abnormal mTOR pathway activity, disorganized communication among brain networks, sensory sensitivity, repetitive behaviors, heightened neuronal activity and increased seizure vulnerability.

Researchers found that a single adult dose of rapamycin, an immune-suppressing drug that affects the mTOR signaling pathway, improved many of these brain and behavioral measures within about two hours. The rapid timing led the team to conclude the drug was likely changing how circuits functioned rather than repairing structural differences established during development. Analyses of brain-cell gene activity suggested especially strong effects in excitatory neurons, pointing to a possible rebalancing of excessive neural activity.

The UCLA researchers emphasized that rapamycin is not being presented as a practical autism treatment for people. ScienceDaily reported that the benefits in mice were temporary, daily use became less effective over several weeks, and the drug can be toxic. The findings are also limited because they come from an animal model of autism-like traits, not a clinical trial.

The study matters because it suggests some functional features linked to early developmental disruption may remain modifiable in adulthood. The authors said the work could guide future research toward safer, more targeted approaches involving sensory circuits, mTOR-related signaling, or the balance between excitation and inhibition in the brain.